1079 related articles for article (PubMed ID: 15925294)
1. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
Czeizel AE; Puhó E
Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
[TBL] [Abstract][Full Text] [Related]
2. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome.
Thurmon TF
Nutrition; 2005 Jun; 21(6):774. PubMed ID: 15925304
[No Abstract] [Full Text] [Related]
3. Acute respiratory infections during pregnancy and congenital abnormalities: a population-based case-control study.
Acs N; Bánhidy F; Puhó EH; Czeizel AE
Congenit Anom (Kyoto); 2006 Jun; 46(2):86-96. PubMed ID: 16732767
[TBL] [Abstract][Full Text] [Related]
4. Using the Hungarian Birth Defects Registry for surveillance, research and intervention.
Siffel C; Czeizel AE
Cent Eur J Public Health; 1997 Jun; 5(2):79-81. PubMed ID: 9208163
[TBL] [Abstract][Full Text] [Related]
5. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
6. Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996.
Czeizel AE; Rockenbauer M; Siffel C; Varga E
Teratology; 2001 May; 63(5):176-85. PubMed ID: 11320528
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study.
Kjaer D; Horvath-Puhó E; Christensen J; Vestergaard M; Czeizel AE; Sørensen HT; Olsen J
BJOG; 2008 Jan; 115(1):98-103. PubMed ID: 17999694
[TBL] [Abstract][Full Text] [Related]
8. Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case-control study.
Palma S; Perez-Iglesias R; Prieto D; Pardo R; Llorca J; Delgado-Rodriguez M
J Epidemiol Community Health; 2008 Feb; 62(2):120-4. PubMed ID: 18192599
[TBL] [Abstract][Full Text] [Related]
9. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
Calda P; Sípek A; Gregor V
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
[TBL] [Abstract][Full Text] [Related]
10. Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? A population-based case-control study.
Bánhidy F; Dakhlaoui A; Puhó EH; Czeizel AA
Congenit Anom (Kyoto); 2011 Jun; 51(2):80-6. PubMed ID: 21039913
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
Khoshnood B; Pryde P; Blondel B; Lee KS
Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
[TBL] [Abstract][Full Text] [Related]
12. Some epidemiological characteristics of Down's syndrome in Hungary.
Czeizel E
Acta Morphol Hung; 1988; 36(1-2):63-77. PubMed ID: 2977471
[TBL] [Abstract][Full Text] [Related]
13. Maternal nutrient intakes and risk of orofacial clefts.
Shaw GM; Carmichael SL; Laurent C; Rasmussen SA
Epidemiology; 2006 May; 17(3):285-91. PubMed ID: 16570024
[TBL] [Abstract][Full Text] [Related]
14. Maternal severe migraine and risk of congenital limb deficiencies.
Bánhidy F; Acs N; Horváth-Puhó E; Czeizel AE
Birth Defects Res A Clin Mol Teratol; 2006 Aug; 76(8):592-601. PubMed ID: 16955495
[TBL] [Abstract][Full Text] [Related]
15. [Atrioventricular septal defect characteristics in infants with and without Down's syndrome: a Lebanese study].
Chéhab G; El-Rassi I; Abdo A; Fakhoury H; Chokor I; Haddad W; Saliba Z
J Med Liban; 2010; 58(1):3-7. PubMed ID: 20358852
[TBL] [Abstract][Full Text] [Related]
16. Prevention of congenital abnormalities by vitamin A.
Czeizel AE; Rockenbauer M
Int J Vitam Nutr Res; 1998; 68(4):219-31. PubMed ID: 9706496
[TBL] [Abstract][Full Text] [Related]
17. Can folic acid protect against congenital heart defects in Down syndrome?
Meijer WM; Werler MM; Louik C; Hernandez-Diaz S; de Jong-van den Berg LT; Mitchell AA
Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):714-7. PubMed ID: 17051586
[TBL] [Abstract][Full Text] [Related]
18. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
19. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
20. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
